University of Southern California

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).

617 total trials 97 currently recruiting 361 completed early-phase tilt top decile by trial count

University of Southern California: 617 sponsored US clinical trials, 97 recruiting.

University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.

Top-decile sponsor footprint

University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 33/100

361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

617 total, page 5 of 13

COMPLETED

Noradrenergic Activity and Attention

NCT05120713

TERMINATED NA

Native American Diabetes Project

NCT05088616

COMPLETED NA

Adolescent Responses to Varying Environments in Virtual Reality Simulations

NCT04465240

COMPLETED NA

Effectiveness of Mindfulness After a Stroke

NCT05029193

TERMINATED Phase 2

High Dose Bupropion for Smoking Cessation - Pilot Study

NCT03326128

COMPLETED NA

Alcohol Metabolism and Disease Risk in Asians

NCT04967599

COMPLETED

UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes

NCT04866953

COMPLETED NA

Video Messages and Vaccination Intention

NCT04979416

COMPLETED

Intra-Operative Complication Assessment and Reporting With Universal Standards: Survey

NCT04994392

COMPLETED NA

Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities

NCT04901624

TERMINATED NA

7T MRI Scan for the Early Detection of Melanoma Brain Metastases

NCT04941430

COMPLETED NA

Fast Arm Motor Skill Training in Chronic Stroke Survivors

NCT05013762

COMPLETED NA

REINVENT: A Brain and Muscle Computer Interface for Stroke

NCT06285175

COMPLETED NA

USC and Bodyport Remote Heart Failure Management Study

NCT04975633

COMPLETED NA

Evaluating a Mobile Phone Intervention

NCT04554706

COMPLETED NA

FASTLANE II: Reducing Sex, Drug, and Mental Health Risk

NCT04109014

TERMINATED Phase 1

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

NCT04387071

TERMINATED NA

Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases

NCT03698162

COMPLETED NA

Virtual Reality Guided Imagery for Chronic Pain

NCT04849897

COMPLETED NA

The HIIT Cognition Study

NCT05137990

COMPLETED NA

Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences

NCT04955717

COMPLETED Early Phase 1

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

NCT04752267

TERMINATED NA

Microbial Growth in Operative Splash Basins During Total Joint Arthroplasty

NCT04274517

COMPLETED

Manipulating Cognitive Intensity During Aerobic Exercise

NCT06479265

COMPLETED NA

Factors Affecting Split Thickness Skin Graft Success Rates in Patients Who Underwent a Radial Forearm or Fibula Free Flap

NCT04648267

COMPLETED NA

Mobile Mindfulness for Alcohol Use and PTSD Among Veterans

NCT04769986

TERMINATED

Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy

NCT04927559

COMPLETED NA

Implementing CAPABLE in PSH

NCT04076319

TERMINATED NA

Knowledge and Interpersonal Skills to Develop Exemplary Relationships

NCT03593564

COMPLETED NA

Mindfulness Training for Smoking Cessation

NCT05440903

COMPLETED NA

Application of Economics & Social Psychology to Improve Opioid Prescribing Safety Trial 1: EHR Nudges

NCT04477304

COMPLETED NA

Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients

NCT04633616

COMPLETED NA

Short-Term Music Training and Auditory Processing in Older Adults

NCT03999606

COMPLETED

Mindfulness After Stroke

NCT04553679

COMPLETED NA

SoCal Savvy: Testing Savvy Caregiver in a Racially and Ethnically Diverse Sample in Southern California

NCT04421729

COMPLETED NA

Effects of e-Cigarettes on Perceptions and Behavior - Remote Substudy # 2

NCT05958992

COMPLETED NA

Effects of e-Cigarettes on Perceptions and Behavior - Remote Substudy # 1

NCT05958979

COMPLETED NA

Habits of Gamers Study

NCT04551976

COMPLETED NA

An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer

NCT04318028

COMPLETED NA

Silk Protein Microparticle-based Filler for Injection Augmentation

NCT03790956

COMPLETED NA

Developing Dynamic Theories for Behavior Change

NCT04043650

TERMINATED Phase 2

Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19

NCT04373044

COMPLETED NA

Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis

NCT03749863

COMPLETED NA

Low Frequency Subthalamic Nucleus Deep Brain Stimulation to Improve Verbal Fluency

NCT04383665

TERMINATED

Fluid Biopsy for the Diagnosis of Lung Cancer

NCT04162678

COMPLETED NA

Effects of e-Cigarettes on Perceptions and Behavior - Substudy 1

NCT04399031

COMPLETED NA

Evaluation of an Intervention for Young Adults With Diabetes: Resilient, Empowered, Active Living-Telehealth (REAL-T)

NCT04023487

COMPLETED NA

Impact of Decision-Framing in Psoriasis

NCT04136314

COMPLETED NA

Music Appreciation After Cochlear Implantation

NCT04099368

COMPLETED NA

Feasibility of a Multi-Level School Intervention for LGBTQ Youth

NCT04041414

← Previous Page 5 of 13 Next →

Phase Distribution

PhaseTrial count
Phase 1 83
Phase 2 90
Phase 3 9
Phase 4 22

What is open in the University of Southern California pipeline

97 recruiting of 617 indexed (16% open); 361 completed (59%).

Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).

Top condition: Obesity (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Southern California: open-pipeline peers nationwide

Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.

University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 0%5%10%15%20% Total trials Recruiting share University of Southern CaliforniaBaylor College of MedicineUS Department of Veterans AffairsUniversity of RochesterJanssen Research & DevelopmentYoungstown State UniversityRoswell Park Cancer InstituteFox Chase Cancer CenterUniversity of Oregon
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 617 trials (± recruiting share)

Sponsors near 16% open enrollment (± trial volume)

What to do with this University of Southern California page

617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.

  • 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Southern California pipeline card: 617 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.